Evidence map›Paper›PMID 37965843›Full record

ArticleChemical research in toxicology2023

Synergistic Effect of Brevetoxin BTX-3 and Ciguatoxin CTX3C in Human Voltage-Gated Na

Sandra Raposo-Garcia, Celia Costas, M Carmen Louzao, Mercedes R Vieytes, Carmen Vale, Luis M Botana

Open access · hybridAbstract read
In one paragraph

Article in Chemical research in toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sandra Raposo-GarciaDepartamento de Farmacología, Farmacia y Tecnología Farmacéutica, Facultad de Veterinaria, IDIS, Universidad de Santiago de Compostela, Campus Universitario s/n, Lugo 27002, Spain.ORCID 0000-0002-2960-4233
Celia CostasDepartamento de Farmacología, Farmacia y Tecnología Farmacéutica, Facultad de Veterinaria, IDIS, Universidad de Santiago de Compostela, Campus Universitario s/n, Lugo 27002, Spain.
M Carmen LouzaoDepartamento de Farmacología, Farmacia y Tecnología Farmacéutica, Facultad de Veterinaria, IDIS, Universidad de Santiago de Compostela, Campus Universitario s/n, Lugo 27002, Spain.ORCID 0000-0002-3072-0637
Mercedes R VieytesDepartamento de Fisiología, Facultad de Veterinaria, Universidad de Santiago de Compostela, Campus Universitario s/n, Lugo 27002, Spain.
Carmen ValeDepartamento de Farmacología, Farmacia y Tecnología Farmacéutica, Facultad de Veterinaria, IDIS, Universidad de Santiago de Compostela, Campus Universitario s/n, Lugo 27002, Spain.ORCID 0000-0002-9842-6223
Luis M BotanaDepartamento de Farmacología, Farmacia y Tecnología Farmacéutica, Facultad de Veterinaria, IDIS, Universidad de Santiago de Compostela, Campus Universitario s/n, Lugo 27002, Spain.
Universidade de Santiago de Compostela · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging marine biotoxins such as ciguatoxins and brevetoxins have been widely and independently studied as food pollutants. Their maximum levels in food components were set without considering their possible synergistic effects as consequence of their coexistence in seafood and their action at the same cellular target. The absolute lack of data and regulations of the possible combined effects that both marine biotoxins may have raised the need to analyze their direct

Indexed as

CiguatoxinsVoltage-Gated Sodium ChannelsAnimalsHumansMarine ToxinsOxocinsPolyether Toxinsbrevetoxinbrevetoxin 3ciguatoxin 3CCiguatoxinsMarine ToxinsOxocinsPolyether ToxinsVoltage-Gated Sodium Channels

Identifiers

PMID37965843
PMCPMC10845145
OpenAlexW4388701167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.